The Mythology of Polymyositis

Suur Biliciler1, Tahseen Mozaffar2

  • 1Department of Neurology, UT Houston, McGovern Medical School, University of Texas, MSE#466 6431 Fannin Street, Houston, TX 77030, USA.

Insights

Polymyositis (PM) diagnosis is historically overemphasized. This review clarifies its rarity compared to other inflammatory myositides, urging a reevaluation of diagnostic practices.

Area of Science:

  • Neurology
  • Rheumatology
  • Medical History

Background:

  • Polymyositis (PM) has been a recognized medical diagnosis since the mid-1800s.
  • Medical training often emphasizes PM, leading to its frequent diagnosis in cases of proximal muscle weakness with elevated creatinine kinase.
  • Historically, many patients received a PM diagnosis without further confirmatory testing.

Purpose of the Study:

  • To explore the historical evolution of the polymyositis diagnosis.
  • To critically examine the diagnostic criteria and application of polymyositis.
  • To contextualize the incidence of polymyositis relative to other inflammatory myopathies.

Main Methods:

  • Literature review focusing on the historical aspects of polymyositis.
  • Analysis of studies addressing the diagnostic prevalence and evolution of polymyositis.
  • Comparative review of polymyositis incidence within the spectrum of inflammatory myositides.

Main Results:

  • The diagnosis of polymyositis has a long history in clinical medicine.
  • There is a historical tendency to overdiagnose polymyositis based on initial symptoms like muscle weakness and elevated creatine kinase.
  • Literature suggests polymyositis is a rare condition when compared to other inflammatory myopathies.

Conclusions:

  • The historical diagnostic approach to polymyositis requires critical reassessment.
  • Understanding the rarity of polymyositis is crucial for accurate differential diagnosis.
  • Further research and refined diagnostic criteria are needed to correctly identify inflammatory myopathies.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
367
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
168
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.8K
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
203
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.9K